AIA to pilot mental wellbeing technology with staff

AIA Australia and New Zealand will be launching a pilot for staff of a corporate health programme provided by mental health technology company Medibio. The pilot marks the latest venture by AIA in seeking out innovative solutions and technologies aimed at improving the health and wellbeing of Australians and New Zealanders.

AIA Australia and New Zealand’s employees will have access to Medibio’s corporate health programme for six months, which promotes mental wellness by checking and monitoring symptoms of depression, anxiety, and stress, and giving users a ‘wellness snapshot’ that they can track and make improvements to over time.

The announcement follows AIA Australia’s recent AIA Vitality 4490 Summit, which explored the ways in which individuals and companies can collaborate to improve corporate health and wellbeing.

AIA Australia and New Zealand CEO Damien Mu said that working with staff on the pilot resonated, because while awareness of the breadth and impact of mental health issues in Australia is increasing, people often do not reach out to their support network or employer until late in the process. “We recognise the crucial role mental health plays in an individual’s overall health. We want to be involved in early intervention, education and awareness.”

-Ends-

MEDIA CONTACT

About AIA Australia

AIA Australia is a leading independent life insurance specialist with over 45 years’ experience. With a unique customer value proposition focused on life, health and wellbeing, our purpose is to make a difference in people’s lives.

AIA Australia offers a range of products that protect and enhance the lives of more than four million Australians. Our vision is to embrace shared value in championing Australia and New Zealand to be the healthiest and most protected nations in the world. With AIA Vitality – the world’s leading scientifically-backed health and wellbeing programme – we help members to live healthier, longer, better lives.

AIA Australia has been recognised with multiple awards, including being named ANZIIF Life Insurance Company of the Year (2017, 2015, 2013, 2012). Further information at www.aia.com.au.

About AIA New Zealand

In New Zealand AIA and Sovereign together employ almost 900 people. Since AIA arrived in New Zealand in 1981, it has consistently provided the market with innovative personal and business insurance products that suit the Kiwi way of life. In July 2018, the AIA Group acquired Sovereign, becoming the largest life insurer in New Zealand. AIA and Sovereign offer a complete range of risk management products that focus on the needs of customers. The companies are both based in Auckland, with regional offices in Hamilton, Wellington and Christchurch. Both companies are members of the Insurance and Financial Services Ombudsman Scheme and the Health Funds Association of New Zealand. AIA has an insurer financial strength rating from Standard and Poor’s of AA-. Sovereign has a rating of A+, from AM Best. 

About Medibio Limited

Medibio (ASX: MEB) (OTCQB: MDBIF) is a mental health technology company that has pioneered the use of objective digital biomarkers to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in Australia, with offices located in Melbourne (Vic), Perth (WA) and U.S. offices in Minneapolis, MN. Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market. Investors can find additional information on www.otcmarkets.com and www.asx.com.au. Website: www.medibio.com.au.